Dive Brief: Bluebird bio will need to wait longer for a decision from the Food and Drug Administration on approval of two gene therapies it …
Gene therapies have the potential to essentially fix many diseases. Yet, those currently in development are administered just once, raising questions about whether their effects …
The U.K. startup has aims to improve on neurodegenerative therapy by using technology developed in a King’s College laboratory run by Christopher Shaw. Shaw is …
The development of safe and effective cell and gene therapies (CGTs) relies on regulatory compliance and critical selection and qualification of raw materials. Regulatory classifications …
Viruses are known to be dangerous pathogens which invade host cells and hi-jack their cellular machinery to direct the replication and transcription of their own …
